AV-1451 PET Imaging of Tau Pathology in Preclinical Alzheimer Disease: Defining a Summary Measure

Utilizing [18F]-AV-1451 tau positron emission tomography (PET) as an Alzheimer disease (AD) biomarker will require identification of brain regions that are most important in detecting elevated tau pathology in preclinical AD. Here, we utilized an unsupervised learning, data-driven approach to identi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuroimage
Päätekijät: Mishra, Shruti, Gordon, Brian A., Su, Yi, Christensen, Jon, Friedrichsen, Karl, Jackson, Kelley, Hornbeck, Russ, Balota, David A., Cairns, Nigel J., Morris, John C., Ances, Beau M., Benzinger, Tammie L.S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696044/
https://ncbi.nlm.nih.gov/pubmed/28756238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroimage.2017.07.050
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia